When to suspect a diagnosis of amyloidosis
I Vaxman, M Gertz - Acta Haematologica, 2020 - karger.com
Amyloidosis is a group of complex diseases caused by extracellular deposition of
pathological insoluble fibrillary protein in organs and tissues and may result in severe organ …
pathological insoluble fibrillary protein in organs and tissues and may result in severe organ …
What is new in diagnosis and management of light chain amyloidosis?
G Palladini, G Merlini - Blood, The Journal of the American …, 2016 - ashpublications.org
Light chain (AL) amyloidosis is caused by a usually small plasma cell clone producing a
misfolded light chain that deposits in tissues. Survival is mostly determined by the severity of …
misfolded light chain that deposits in tissues. Survival is mostly determined by the severity of …
AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy
RH Falk, KM Alexander, R Liao, S Dorbala - Journal of the American …, 2016 - jacc.org
The amyloidoses are a group of protein-folding disorders in which≥ 1 organ is infiltrated by
proteinaceous deposits known as amyloid. The deposits are derived from 1 of several …
proteinaceous deposits known as amyloid. The deposits are derived from 1 of several …
Recent advances in the diagnosis, risk stratification, and management of systemic light-chain amyloidosis
I Vaxman, M Gertz - Acta Haematologica, 2019 - karger.com
The term amyloidosis refers to a group of disorders in which protein fibrils accumulate in
certain organs, disrupt their tissue architecture, and impair the function of the effected organ …
certain organs, disrupt their tissue architecture, and impair the function of the effected organ …
New developments in diagnosis, risk assessment and management in systemic amyloidosis
I Vaxman, A Dispenzieri, E Muchtar, M Gertz - Blood reviews, 2020 - Elsevier
Amyloidosis is a group of disorders characterized by a misfolded protein that deposits in
organs and compromise their function. Clinician should have a high index of suspicion …
organs and compromise their function. Clinician should have a high index of suspicion …
Immunoglobulin light-chain amyloidosis: from basics to new developments in diagnosis, prognosis and therapy
Immunoglobulin amyloid light-chain (AL) amyloidosis is the most common form of systemic
amyloidosis, where the culprit amyloidogenic protein is immunoglobulin light chains …
amyloidosis, where the culprit amyloidogenic protein is immunoglobulin light chains …
Current trends in diagnosis and management of cardiac amyloidosis
BL Esplin, MA Gertz - Current problems in cardiology, 2013 - Elsevier
Amyloidosis is a rare disease in which insoluble extracellular protein fibrils in β-pleated
sheets infiltrate multiple organs, causing organ dysfunction and failure. Amyloidoses are …
sheets infiltrate multiple organs, causing organ dysfunction and failure. Amyloidoses are …
Amyloidosis: pathogenesis and new therapeutic options
G Merlini, DC Seldin, MA Gertz - Journal of Clinical Oncology, 2011 - ascopubs.org
The systemic amyloidoses are a group of complex diseases caused by tissue deposition of
misfolded proteins that results in progressive organ damage. The most common type …
misfolded proteins that results in progressive organ damage. The most common type …
Pitfalls in the diagnosis of primary amyloidosis
Primary (AL) amyloidosis is the most prevalent type of systemic amyloidosis, and
management of this disease has evolved through the years from supportive care to …
management of this disease has evolved through the years from supportive care to …
Cardiac amyloid load: a prognostic and predictive biomarker in patients with light-chain amyloidosis
AV Kristen, E Brokbals, F aus dem Siepen… - Journal of the American …, 2016 - jacc.org
Background: Cardiac amyloid load has not been analyzed for its effect on mortality in
patients with amyloid light-chain (AL) cardiac amyloidosis. Objectives: This study …
patients with amyloid light-chain (AL) cardiac amyloidosis. Objectives: This study …